Drug Type Synthetic peptide |
Synonyms BMS 234475, BMS-234475, CGP 61755 + [1] |
Target |
Action inhibitors |
Mechanism HIV-1 pol inhibitors(Human immunodeficiency virus type 1 Pol protein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC35H53N3O9 |
InChIKeyBEUUJDAEPJZWHM-COROXYKFSA-N |
CAS Registry175385-62-3 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Lasinavir | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| HIV Infections | Phase 1 | United States | - | |
| HIV Infections | Phase 1 | - | - |






